Literature DB >> 23565856

Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi.

Anne-Cécile Normand1, Carole Cassagne, Stéphane Ranque, Coralie L'ollivier, Patrick Fourquet, Sam Roesems, Marijke Hendrickx, Renaud Piarroux.   

Abstract

BACKGROUND: The poor reproducibility of matrix-assisted desorption/ionization time-of-flight (MALDI-TOF) spectra limits the effectiveness of the MALDI-TOF MS-based identification of filamentous fungi with highly heterogeneous phenotypes in routine clinical laboratories. This study aimed to enhance the MALDI-TOF MS-based identification of filamentous fungi by assessing several architectures of reference spectrum libraries.
RESULTS: We established reference spectrum libraries that included 30 filamentous fungus species with various architectures characterized by distinct combinations of the following: i) technical replicates, i.e., the number of analyzed deposits for each culture used to build a reference meta-spectrum (RMS); ii) biological replicates, i.e., the number of RMS derived from the distinct subculture of each strain; and iii) the number of distinct strains of a given species. We then compared the effectiveness of each library in the identification of 200 prospectively collected clinical isolates, including 38 species in 28 genera.Identification effectiveness was improved by increasing the number of both RMS per strain (p<10-4) and strains for a given species (p<10-4) in a multivariate analysis.
CONCLUSION: Addressing the heterogeneity of MALDI-TOF spectra derived from filamentous fungi by increasing the number of RMS obtained from distinct subcultures of strains included in the reference spectra library markedly improved the effectiveness of the MALDI-TOF MS-based identification of clinical filamentous fungi.

Entities:  

Mesh:

Year:  2013        PMID: 23565856      PMCID: PMC3691839          DOI: 10.1186/1471-2180-13-76

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


Background

The identification of mold in the clinical laboratory is classically based on macroscopic and microscopic examination of the colonies grown on mycological culture media. It is a slow and complex process requiring highly skilled mycologists, and misidentifications may occur, even in experienced reference laboratories [1]. Additionally, some distinct species, which are identified via DNA sequence analysis, are morphologically indistinguishable [2-4]. Therefore, multilocus DNA sequence analysis represents the recommended approach to accurately identify these microorganisms. Nevertheless, the DNA sequence-based identification of filamentous fungi is primarily limited by the following: i) low DNA extraction yields because mold cells are difficult to lyse, ii) the presence of PCR inhibitors, iii) the presence of misidentified sequences in non-curated public DNA sequence databases, and iv) the cost and time required for sequencing. Currently, only some clinical laboratories routinely use a molecular approach for microorganism identification, which is primarily due to the cost and application constraints [5,6]. Recently, matrix-assisted desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) has been applied to rapidly identify bacteria and yeasts in the clinical microbiology laboratory setting [7]. This technique is used to analyze microorganism content (primarily ribosomal proteins), thereby generating a spectrum that is considered the fingerprint of the microorganism [8]. Using this technique, the identification of an unknown organism is performed by comparing the corresponding spectrum to a reference library of spectra. When establishing a reference library for microbial identification purposes, many authors have used reference mass spectra, sometimes referred to as “metaspectra” or “superspectra”, which are generated by combining the results of a various number of individual spectra corresponding to technical replicates of a given sample. Previous studies have indicated that MS could be used to identify various filamentous fungi taxa of clinical interest, including Fusarium spp [9-11], dermatophytes [12,13], Aspergillus spp [14,15], and Pseudallescheria/Scedosporium spp [16]; those of industrial interest, including Penicillium spp [17,18], Verticillium spp [19], and Trichoderma spp [20]; and various filamentous fungal contaminants frequently isolated in the clinical laboratory [21,22]. The heterogeneous morphological phenotypes of filamentous fungi affect the identification process. As shown in Figure 1, the same heterogeneity exists for MALDI-TOF mass spectra, between different strains of the same species as well as between subcultures of the same strain, which negatively impacts the reproducibility of the spectra. To troubleshoot this issue, we accounted for this heterogeneity during the establishment of the RMS library (MSL). We hypothesized that MS identification effectiveness could be enhanced by increasing both the number of reference meta spectra (RMS) of a given strain included in the reference library and the number of deposits used to generate each RMS. The primary objective of this study was to test the effectiveness of distinct reference spectra library architectures for the MALDI-TOF MS-based identification of filamentous fungi. More precisely, we assessed the influence on identification effectiveness of the following: i) the number of technical replicates, i.e., the number of analyzed deposits (spots) from one culture used to generate an RMS; ii) the number of biological replicates, i.e., the number of RMS derived from distinct subcultures for each strain; and iii) the number of distinct strains of one species used to construct the library.
Figure 1

Comparison of mass spectra obtained from four subcultures of a strain of The Aspergillus flavus 1027804 strain was subcultured on four different agar plates. Spectra A, B, C, and D display the first spectrum acquired from the subcultures 1, 2, 3 and 4, respectively. Spectra A to D display many common peaks; however, a few varying peaks are also clearly visible and characteristic of one of the subcultures.

Comparison of mass spectra obtained from four subcultures of a strain of The Aspergillus flavus 1027804 strain was subcultured on four different agar plates. Spectra A, B, C, and D display the first spectrum acquired from the subcultures 1, 2, 3 and 4, respectively. Spectra A to D display many common peaks; however, a few varying peaks are also clearly visible and characteristic of one of the subcultures.

Results

Phenotypic and genotypic identification of clinical isolates

The results of the classical and DNA sequence-based identification of 200 clinical isolates (Table 1) were applied to classify the isolates into two groups: isolates included and isolates excluded from the MSL. The MS results of both groups are summarized in Table 2. The isolates belonged to 28 different genera and 38 different species. Moreover, 174 isolates corresponded to 18 species, which were represented among those used to construct the eight libraries, whereas the 26 remaining isolates belonged to 20 species that were not represented in the libraries.
Table 1

Identification of the 200 clinical isolates included in the study

SpeciesNumber of IsolatesCorresponding RMS in the MSLs
Acremonium sp.
1
no
Alternaria alternata
10
yes
Aspergillus alliaceus
2
no
Aspergillus clavatus
1
no
Aspergillus flavus
8
yes
Aspergillus fumigatus
82
yes
Aspergillus melleus
1
no
Aspergillus nidulans
1
yes
Aspergillus niger
12
yes
Aspergillus oryzae
1
no
Aspergillus sydowii
1
no
Aspergillus terreus
11
yes
Beauveria bassiana
1
yes
Chaetomium globosum
1
no
Fomitopsis ostreiformis
1
no
Fusarium oxysporum
2
yes
Geotrichum candidum
2
no
Hamigera avellanea
1
no
Hypocrea jecorina
1
no
Microsporum audouinii
10
yes
Microsporum canis
1
yes
Onychocola canadensis
1
no
Penicillium aurantiogriseum
1
yes
Penicillium chrysogenum
7
yes
Penicillium citrinum
1
no
Penicillium funiculosum
1
no
Penicillium glabrum
4
no
Penicillium oxalicum
1
no
Penicillium pinophilum
1
no
Penicillium variotii
1
yes
Penicillum spinulosum
2
no
Rhizopus oryzae
3
yes
Scedosporium apiospermium
8
yes
Trichoderma atroviridae
1
no
Trichoderma viridae
1
no
Trichophyton mentagrophytes
2
yes
Trichophyton rubrum
8
yes
Trichophyton soudanense6yes

RMS: reference mass spectrum in the mass spectra library (MSL) constructed from several raw spectra.

Table 2

Details of the MS-based identification results of the 200 clinical isolates included in the study

 
Mass spectra libraries
 B0B1B2B3B4B5B6B7
Isolates included in the MSLs (n=174)
Nb. of concordant identifications
481
449
495
521
494
475
586
611
Median value of concordant LS1 values
1.59
1.58
1.65
1.73
1.67
1.67
1.99
2.02
Nb. of concordant values with LS1>1.7
182
180
222
282
225
225
443
494
Percentage of concordant values with LS1>1.7
37.8
40.1
44.8
54.1
45.5
47.4
75.6
80.9
Range of concordant LS1 values
0.49 - 2.39
0.29 - 2.45
0.50 - 2.45
0.66 - 2.57
0.18 - 2.44
0.70 - 2.44
0.60 - 2.57
0.77 - 2.57
Nb. of non-concordant identifications
225
257
211
184
212
231
119
95
Median value of non-concordant LS1 values
0.99
1.07
1.1
1.23
1.15
1.07
1.26
1.28
Range of non-concordant LS1 values
0.29 - 1.44
0.14 - 1.55
0.27 - 1.58
0.43 - 1.58
0.25 - 1.85
0.14 - 1.52
0.65 - 1.69
0.69 - 1.69
Isolates not included in the MSLs (n=26)
Nb. of concordant identifications
0
0
0
0
0
0
0
0
Median values of concordant LS1 values
-
-
-
-
-
-
-
-
Minimum and maximum values of the concordant LS1
-
-
-
-
-
-
-
-
Nb. of non-concordant identifications
104
104
104
104
104
104
104
104
Median values of non-concordant LS1 values
1.02
1.09
1.18
1.24
1.22
1.14
1.31
1.33
Range of non-concordant LS1 values0.50 - 1.390.45 - 1.430.46 - 1.440.56 - 1.560.52 - 1.540.54 - 1.490.76 - 1.790.88 - 1.79

Concordant LS1: LS value for the first concordant identification with the library; non-concordant LS1: LS value for the first non-concordant identification with the library; Nb.: number.

Identification of the 200 clinical isolates included in the study RMS: reference mass spectrum in the mass spectra library (MSL) constructed from several raw spectra. Details of the MS-based identification results of the 200 clinical isolates included in the study Concordant LS1: LS value for the first concordant identification with the library; non-concordant LS1: LS value for the first non-concordant identification with the library; Nb.: number.

Reference MS library validation

All 104 spectra derived from the 26 clinical isolates for which the species was not included in the seven MS libraries (4 raw spectra per clinical isolate) yielded low Log Scores (LS) ranging from 0.45 to 1.79 (only 1/104 spectra yielded LS>1.7: Penicillium aurantiogriseum identified instead of Geotrichum candidum) regardless of the library utilized, which is markedly below the manufacturer recommended threshold of 2.00 for a valid identification. The number of correct identifications among the 706 remaining spectra (i.e., corresponding to the species included in the libraries) and the corresponding LS values were statistically different depending on the mass spectra library used for identification (Figures 2 and 3). Notably, the number of identifications concordant with the molecular biology or microscopic identification and LS values significantly increased when the library included an increased number of both RMS per strain and strains per species. In contrast, constructing RMS from 40 raw spectra (B5) instead of 10 raw spectra or reducing the number of raw spectra used to build RMS of the B1 library from 10 to 4 (B0) failed to significantly alter the performance of the identification process (Table 3, Figure 3). Overall, the best results were obtained using library B7, which involved the combination of the highest number of RMS per strain and the highest number of strains per species. Using this library, we obtained 611 (87%) concordant identifications, with LS values higher than 1.700 in 80.85% (494/611) of the cases and LS values higher than 2.000 in 50.90% (311/611) of the cases. Conversely, all 91 (13%) non-concordant identifications exhibited LS values less than 1.700, a value under which the results of LS identification should not be taken in account. These results were dramatically improved compared with those obtained using library B1, which included only one isolate per species and one subculture per isolate. Indeed, using the B1 library, we only obtained 449 (64%) concordant identifications, 40.09% of which displayed LS values higher than 1.7 (180/449) and only 15.59% were higher than 2.000 (70/449). Modulation of the MSP creation parameters, while considering the B1 library, tended to show that the performance of the database could be improved by an increased peak frequency minimum, regarding the number of concordant identifications and the Log Score of the first identification (LS1) mean value. However, when these parameters were applied to the B7 library, we observed the opposite result (Table 4).
Figure 2

Distribution of the LS1 values. Box-and-whisker diagrams of the LS1 values associated with the concordant mass spectral identifications (black) and the non-concordant identifications (gray) obtained using the seven different mass spectrum libraries tested (B1 to B7). The lower and upper portions of the box represent the lower and upper quartiles, respectively. The dark band represents the median value. The ends of the whiskers represent the lowest datum included in the 1.5 inter-quartile range (IQR) of the lower quartile and the highest datum included in the 1.5 IQR of the upper quartile. Outlier values are represented by a circle; a.u.: arbitrary unit.

Figure 3

Number of correct and false MALDI-TOF MS-based identifications obtained with the seven mass spectral libraries. A bar graph showing the number of concordant and non-concordant MALDI-TOF MS-based identifications obtained with each of the seven different mass spectral libraries, B1 to B7, for the 174 isolates. The horizontal bar represents the significance of the McNemar’s test between the designated MSLs (★ p≤0.01; Nb.: number; MSLs, mass spectral libraries).

Table 3

The performance of the libraries considering the species and treatment applied to the clinical quadruplicates

 
 
Independent spots
Best of 4 spots
Clinical isolate MSP for 4 spots
Species B0B1B2B3B4B5B6B7B0B1B2B3B4B5B6B7B0B1B2B3B4B5B6B7
Alternaria alternata (10)
a
70
73
80
88
88
83
95
95
60
70
90
90
80
90
100
100
80
80
80
80
80
70
100
100
b
1.67
1.83
1.84
1.82
1.78
1.71
1.91
1.95
1.91
1.96
1.87
1.89
1.81
1.79
1.98
2.02
1.63
1.7
1.81
1.84
1.74
1.77
1.85
1.92
Aspergillus flavus (8)
a
91
78
81
88
88
94
94
100
88
88
100
100
100
100
100
100
88
75
63
63
75
88
88
100
b
1.58
1.64
1.68
1.73
1.65
1.72
1.74
2.01
1.8
1.76
1.73
1.77
1.73
1.8
1.83
2.09
1.54
1.66
1.93
1.95
1.77
1.77
2.02
2.03
Aspergillus fumigatus (85)
a
84
79
84
88
86
85
96
97
92
91
91
91
93
89
98
98
88
85
87
87
86
88
99
98
b
1.58
1.59
1.67
1.77
1.7
1.71
2.03
2.04
1.69
1.69
1.77
1.87
1.78
1.82
2.13
2.14
1.58
1.6
1.67
1.76
1.69
1.64
2.05
2.08
Aspergillus nidulans (2)
a
29
14
14
43
57
29
14
43
50
50
50
50
100
50
50
50
50
50
50
50
100
50
50
50
b
1.37
1.89
1.89
1.56
1.53
1.39
1.89
1.82
1.58
1.89
1.89
1.89
1.52
1.49
1.89
1.89
1.64
1.62
1.62
1.63
1.41
1.14
1.63
1.83
Aspergillus niger (12)
a
85
83
81
77
65
63
77
83
92
83
83
83
67
67
83
83
83
83
75
75
75
75
92
83
b
1.56
1.57
1.59
1.66
1.54
1.55
1.77
1.89
1.67
1.67
1.68
1.73
1.69
1.71
1.83
1.97
1.53
1.47
1.58
1.65
1.57
1.47
1.6
1.89
Aspergillus terreus (10)
a
28
25
33
35
28
25
55
63
30
30
40
40
40
40
60
70
50
40
50
50
50
40
70
70
b
1.23
1.14
1.19
1.3
1.22
1.22
1.67
1.61
1.35
1.29
1.36
1.41
1.41
1.35
1.79
1.7
1.06
1.17
1.14
1.2
1.21
1.24
1.66
1.66
Beauveria bassiana (1)
a
0
0
100
100
75
75
75
75
0
0
100
100
100
100
100
100
0
0
0
0
0
0
0
0
b
 
 
1.2
1.2
1.05
0.93
1.24
1.26
 
 
1.32
1.32
1.12
1.06
1.32
1.32
 
 
 
 
 
 
 
 
Fusarium oxysporum (2)
a
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
b
1.93
2.06
2.06
2.07
1.82
1.78
2.11
2.12
2
2.11
2.11
2.11
1.98
2
2.16
2.17
1.97
2.06
2.06
2.06
1.79
1.9
2.06
2.06
Microsporum audouinii (10)
a
45
33
30
30
40
33
30
65
60
50
50
50
40
40
50
70
50
50
50
50
30
40
50
80
b
1.49
1.4
1.44
1.57
1.35
1.47
1.59
1.8
1.59
1.54
1.55
1.7
1.64
1.67
1.7
1.91
1.41
1.2
1.38
1.45
1.59
1.33
1.54
1.71
Microsporum canis (1)
a
0
0
0
0
0
0
25
50
0
0
0
0
0
0
0
100
0
0
0
0
0
0
0
100
b
 
 
 
 
 
 
1.17
1.51
 
 
 
 
 
 
 
1.56
 
 
 
 
 
 
 
1.65
Penicillium aurantiogriseum/chrysogenum (8)
a
34
34
44
63
41
28
75
75
38
25
50
63
50
38
75
75
50
0
0
0
0
0
38
50
b
1.7
1.59
1.58
1.88
1.64
1.88
1.98
2
1.86
2.1
1.72
2.03
1.65
1.87
2.19
2.19
1.75
 
 
 
 
 
2.07
2.11
Paecilomyces variotii (1)
a
0
0
0
0
0
0
25
25
0
0
0
0
0
0
100
100
0
0
0
0
0
0
0
100
b
 
 
 
 
 
 
1.2
1.28
 
 
 
 
 
 
1.2
1.28
 
 
 
 
 
 
 
1.76
Rhizopus oryzae (3)
a
58
50
58
75
50
58
75
75
67
67
100
100
33
67
100
100
67
67
100
100
67
67
67
67
b
1.64
2.14
2.05
2.05
1.89
1.69
2.05
2.05
2.03
2.15
1.95
2.06
2.28
1.92
2.06
2.06
1.89
2.16
1.84
1.92
2.02
1.75
2.27
2.27
Scedosporium apiospermum (8)
a
47
44
41
47
44
41
56
66
50
50
50
63
38
38
50
63
50
50
63
63
38
63
63
75
b
1.53
1.33
1.45
1.56
1.59
1.52
1.62
1.67
1.69
1.63
1.65
1.71
1.96
1.81
1.84
1.9
1.97
1.83
1.88
1.9
2.26
1.81
1.96
2.02
Trichophyton mentagrophytes (2)
a
88
63
100
100
88
100
100
100
100
50
100
100
50
100
100
100
100
50
100
100
50
100
100
100
b
1.91
1.93
1.9
1.93
1.8
1.67
1.94
1.94
1.92
2.37
1.97
2.01
2.44
1.74
2.01
2.01
1.84
2.35
1.96
2.01
2.47
1.69
2.01
2.01
Trichophyton rubrum (8)
a
47
50
53
69
53
53
78
69
50
75
88
75
63
63
88
75
63
50
63
63
63
38
63
50
b
1.11
1.13
1.28
1.43
1.47
1.29
1.51
1.65
1.52
1.27
1.35
1.5
1.64
1.54
1.63
1.83
1.35
1.07
1.38
1.46
1.47
1.81
1.54
1.74
Trichophyton soudanense (6)
a
17
17
71
38
46
13
92
88
0
17
67
50
50
0
100
100
0
50
67
50
50
17
83
100
b
1.08
1.24
1.39
1.46
1.37
1.17
1.91
1.97
 
1.35
1.48
1.53
1.42
 
2
2.02
 
0.96
1.03
1.08
1.21
0.86
2
1.9
All species in the library (177)
a
68
64
70
74
70
67
83
87
73
72
80
80
75
72
88
90
73
69
72
72
69
68
84
88
b
1.56
1.58
1.64
1.73
1.65
1.65
1.92
1.96
1.7
1.7
1.73
1.82
1.75
1.78
2.01
2.05
1.58
1.57
1.64
1.72
1.67
1.63
1.94
2
Non-A. fumigatus species included in the library (92)a
53
50
57
61
56
51
71
77
55
55
70
70
59
57
78
83
60
54
59
58
53
51
71
78
b1.541.571.591.681.581.581.781.861.721.71.671.761.71.711.871.951.571.521.61.661.641.611.811.9

a: percentage of concordant identification, b: LS mean of the concordant identifications.

Table 4

Modulation of the database performance for independent spots regarding the MSP creation parameters

LibrariesLS1 meanNb. of concordant identificationsLS1 mean of concordant identificationsNb. of non-concordant identificationsLS1 mean of non -concordant identificationsMean of the difference between LS1 and LS2Max frequency parameter (%)Nb. of peaks parameter
B1
1.34
449
1.58
361
1.04
0.38
25
70
B1b
1.34
449
1.58
361
1.04
0.38
25
100
B1c
1.34
449
1.58
361
1.04
0.38
50
70
B1d
1.36
473
1.60
337
1.03
0.40
50
100
B1e
1.34
449
1.58
361
1.04
0.38
75
70
B1f
1.32
445
1.56
365
1.03
0.36
75
100
B1g
1.39
473
1.63
337
1.05
0.43
100
70
B1h
1.39
473
1.63
337
1.05
0.43
100
100
B7
1.80
611
1.96
199
1.30
0.53
25
70
B7g1.805951.962151.350.5010070
Distribution of the LS1 values. Box-and-whisker diagrams of the LS1 values associated with the concordant mass spectral identifications (black) and the non-concordant identifications (gray) obtained using the seven different mass spectrum libraries tested (B1 to B7). The lower and upper portions of the box represent the lower and upper quartiles, respectively. The dark band represents the median value. The ends of the whiskers represent the lowest datum included in the 1.5 inter-quartile range (IQR) of the lower quartile and the highest datum included in the 1.5 IQR of the upper quartile. Outlier values are represented by a circle; a.u.: arbitrary unit. Number of correct and false MALDI-TOF MS-based identifications obtained with the seven mass spectral libraries. A bar graph showing the number of concordant and non-concordant MALDI-TOF MS-based identifications obtained with each of the seven different mass spectral libraries, B1 to B7, for the 174 isolates. The horizontal bar represents the significance of the McNemar’s test between the designated MSLs (★ p≤0.01; Nb.: number; MSLs, mass spectral libraries). The performance of the libraries considering the species and treatment applied to the clinical quadruplicates a: percentage of concordant identification, b: LS mean of the concordant identifications. Modulation of the database performance for independent spots regarding the MSP creation parameters Considering Aspergillus fumigatus isolates separately, the results ranged from 79% (B0/B1) to 97% (B7) concordant identifications, whereas for other species, the percentage of concordant identification ranged from 56% (B0/B1) to 79% (B7) (Table 3). Finally, the identification of a clinical isolate, regardless of the species, was not improved by creating metaspectra (MSP) of the 4 spectra for the comparison of the various libraries (Table 3). The multivariate analysis findings (Table 5) indicate that concordant identification rates increased significantly with the number of both RMS per strain and raw spectra per RMS. Similarly, the LS values significantly increased (p<10-4) with the independent effect of the numbers of RMS per strain and raw spectra per RMS (data not shown). The independent effect of the number of raw spectra per RMS was weaker than the effect of the number of RMS per strain. The percentage of concordant identifications significantly increased exclusively when the number or raw spectra per RMS exceeded 20 (i.e., 40 raw spectra per RMS).
Table 5

Multivariate analysis of the factors influencing the probability of the concordant identification of clinical isolates

  OR95% Confidence Interval P
Nb. raw spectra/RMS
 
 
 
 
 
40 vs. 10
1.1767
1.0503 to 1.3183
 
0.0050
 
40 vs. 20
1.2007
1.0705 to 1.3466
 
0.0018
 
20 vs. 10
0.9800
0.8933 to 1.0752
 
0.6698
Nb. RMS/strain
 
 
 
 
 
4 vs. 1
1.3362
1.1929 to 1.4968
<10-4
 
 
4 vs. 2
1.1016
1.0122 to 1.1988
 
0.0250
 
2 vs. 1
1.2130
1.0950 to 1.3437
 
0.0002
Nb. strains/species
 
 
 
 
 
3 vs. 1
1.2229
1.1173 to 1.3385
<10-4
 
 
3 vs. 2
1.0602
1.0095 to 1.1135
 
0.0193
 2 vs. 11.15341.0683 to 1.2453 0.0003

RMS: reference mass spectrum in the library constructed from several raw spectra. Nb.: number.

Multivariate analysis of the factors influencing the probability of the concordant identification of clinical isolates RMS: reference mass spectrum in the library constructed from several raw spectra. Nb.: number.

Discussion

In contrast with recurrent efforts to improve the reproducibility of the MS-based identification of filamentous fungi by standardizing the pre-treatment procedures, we report the first study aiming to improve identification by comparing the effectiveness of distinct RMS library architectures. However, in a recently published study aiming to identify filamentous fungi using MS, de Carolis et al. [22] have shown that some of the mass spectra data obtained during routine diagnosis matched preferentially with the RMS obtained from either young or mature cultures of the same species. Regarding Scedosporium identification, Coulibaly et al. [16] have shown that both the culture media and the duration of culture had a significant impact on MALDI-TOF assay results. However, the standard recommendation to address problems associated with the heterogeneity of microorganism species is merely to increase the number of strains per species in the library. Our findings confirm this hypothesis; however, it is particularly challenging to increase the number of well-characterized strains included in the RMS library for each fungal species. Numerous species have been described to play a role in human infections and, in many cases, only a single strain or a few strains of the same species are preserved in international collections. In the current study, we demonstrated that increasing the number of mass spectra generated from distinct subcultures of a given strain yields a significant improvement in the process of filamentous fungi identification and can partially offset the relatively low number of specific strains available to construct RMS libraries. Modulating MSP creation parameters yielded discrepant results depending on the database that was taken into account. As the B7 database appears ideal for filamentous fungi identification, Bruker’s default parameters for the MSP creation method seem to be more suitable for library construction. Conversely, the number of spectra derived from a strain (4, 10, 20, or 40) that were used to construct RMS did not result in a marked improvement of the identification performance. This straightforward optimization of RMS library architecture significantly enhanced the identification effectiveness. In this study, we used quadruplicates of the clinical samples to test the various RMS libraries. By taking only the spectrum with the highest LS value into account, we observed an increased percentage of concordant identifications (e.g., ranging from 87% to 90% with library B7). In parallel, using the four clinical replicates to construct an MSP and then compare it to the various libraries did not alter the results but instead tended to complicate the procedure, as this cannot be performed with RTC software during routine analyses. The use of standardized conditions (incubation time, temperature, and culture medium) [10,15-18] reduces filamentous fungi pleomorphism but does not preclude the heterogeneity of the mass spectra derived from a given isolate. For example, Chen et al. [17] have improved the accuracy of Penicillium identification by assessing the presence or absence of different species-specific peaks in the mass spectrum data obtained when analyzing Penicillium spores; however, separating spores from hyphae significantly complicates the pre-processing step. Conversely, some authors have shown that mass spectra heterogeneity is reduced using non-sporulating hyphae obtained in broth culture conditions [21-23]. Unfortunately, the more stringent the method, the less suited it is for high-throughput routine diagnoses. Furthermore, certain impediments are difficult to avoid in routine culture conditions, such as inter-technician variations, variation in protocol, and minor variations (temperature, humidity, or light), when aiming to standardize such protocols.

Conclusion

Overall, this study provides useful insight into architecture design of reference MS libraries utilized for the MALDI-TOF MS–based identification of filamentous fungi in routine clinical laboratories. Our results show that both incorporating an increased number of subcultures from each strain and increasing the number of strains representing each species are key to improve the architecture of RMS libraries. These findings should be taken into account to construct a more effective library in clinical laboratories.

Methods

Fungal strains

The 90 reference filamentous fungus strains corresponding to 30 distinct species that were used to construct the eight distinct reference mass spectrum libraries are detailed in Table 6. Of the 90 reference strains, 63 strains were graciously provided by the BCCM/IHEM (Belgian coordinated collection of microorganisms, Scientific Institute of Public Health, Mycology and Aerobiology Section, Brussels, Belgium), and 3 strains were provided by the Pasteur Institute (Paris, France). The remaining 24 strains were clinical isolates from the Marseille University Hospital mycology laboratory, which were accurately identified via DNA sequence analysis as described below. All strains used to construct the reference database are preserved in the BCCM/IHEM collection. The identification performance of each reference library was tested using 200 clinical isolates from the Marseille University Hospital mycology laboratory.
Table 6

Details of the 90 reference strains corresponding to 30 filamentous fungi species of medical interest included in the reference libraries

SpeciesStrainSourceIncluded in library(ies)
Absidia corymbifera
IHEM16288
BCCM/IHEM
B0-B7
IHEM14734
BCCM/IHEM
B6-B7
IHEM21658
BCCM/IHEM
B7
Acremonium strictum
Pasteur 173
Pasteur Institute
B7
IHEM19179
BCCM/IHEM
B0-B7
IHEM 22371
BCCM/IHEM
B6-B7
Acrophialophora fusispora
IHEM15939
BCCM/IHEM
B0-B7
IHEM19591
BCCM/IHEM
B6-B7
IHEM19730
BCCM/IHEM
B7
Alternaria alternata
IHEM22669
BCCM/IHEM
B6-B7
IHEM21999
BCCM/IHEM
B0-B7
IHEM9788
BCCM/IHEM
B7
Aspergillus candidus
IHEM15975
BCCM/IHEM
B6-B7
IHEM14607
BCCM/IHEM
B7
IHEM9678
BCCM/IHEM
B0-B7
Aspergillus flavus
IHEM23376
BCCM/IHEM
B6-B7
IHEM14475
BCCM/IHEM
B0-B7
AFLA002
clinical strain
B7
Aspergillus fumigatus
IHEM15161
BCCM/IHEM
B0-B7
IHEM19416
BCCM/IHEM
B6-B7
IHEM22145
BCCM/IHEM
B7
Aspergillus nidulans
IHEM23179
BCCM/IHEM
B0-B7
IHEM23366
BCCM/IHEM
B6-B7
Pasteur 123
Pasteur Institute
B7
Aspergillus nigri section
IHEM9673
BCCM/IHEM
B0-B7
IHEM5077
BCCM/IHEM
B6-B7
ANIG001
clinical strain
B7
Aspergillus terreus
IHEM17777
BCCM/IHEM
B0-B7
IHEM18939
BCCM/IHEM
B6-B7
IHEM9995
BCCM/IHEM
B7
Beauveria bassiana
IHEM6954
BCCM/IHEM
B6-B7
Pasteur 146
Pasteur Institute
B7
IHEM18747
BCCM/IHEM
B0-B7
Exophiala dermatitidis
EXOP001
clinical strain
B7
IHEM23421
BCCM/IHEM
B0-B7
IHEM9780
BCCM/IHEM
B6-B7
Fusarium oxysporum
IHEM18448
BCCM/IHEM
B0-B7
FUSA003
clinical strain
B7
IHEM20619
BCCM/IHEM
B6-B7
Fusarium solani
IHEM22015
BCCM/IHEM
B0-B7
IHEM7504
BCCM/IHEM
B6-B7
1000694
clinical strain
B7
Fusarium verticillioides
IHEM20180
BCCM/IHEM
B6-B7
IHEM22962
BCCM/IHEM
B7
IHEM18495
BCCM/IHEM
B0-B7
Microsporum audouinii
013
clinical strain
B0-B7
027
clinical strain
B6-B7
169
clinical strain
B7
Microsporum canis
05-05-00921
clinical strain
B0-B7
249
clinical strain
B6-B7
1100085
clinical strain
B7
Microsporum gypseum
05-05-00961
clinical strain
B0-B7
MO
clinical strain
B6-B7
93629
clinical strain
B7
Paecilomyces variotii
IHEM17703
BCCM/IHEM
B6-B7
IHEM3285
BCCM/IHEM
B7
IHEM16627
BCCM/IHEM
B0-B7
Penicillium aurantiogriseum
IHEM18723
BCCM/IHEM
B0-B7
IHEM20176
BCCM/IHEM
B6-B7
IHEM20357
BCCM/IHEM
B7
Penicillium chrysogenum
IHEM17894
BCCM/IHEM
B0-B7
IHEM22667
BCCM/IHEM
B6-B7
IHEM20859
BCCM/IHEM
B7
Rhizomucor pusillus
IHEM21236
BCCM/IHEM
B0-B7
IHEM18686
BCCM/IHEM
B6-B7
IHEM16462
BCCM/IHEM
B7
Rhizopus oryzae
IHEM13186
BCCM/IHEM
B0-B7
IHEM21660
BCCM/IHEM
B7
IHEM16287
BCCM/IHEM
B6-B7
Scedosporium apiospermum
IHEM3817
BCCM/IHEM
B7
IHEM6908
BCCM/IHEM
B6-B7
IHEM14632
BCCM/IHEM
B0-B7
Scedosporium prolificans
IHEM5739
BCCM/IHEM
B0-B7
IHEM18755
BCCM/IHEM
B6-B7
IHEM22339
BCCM/IHEM
B7
Scopulariopsis brevicaulis
IHEM15574
BCCM/IHEM
B0-B7
IHEM1690
BCCM/IHEM
B6-B7
IHEM22982
BCCM/IHEM
B7
Trichophyton mentagrophytes
1036279
clinical strain
B0-B7
1039316
clinical strain
B6-B7
5-97-00858
clinical strain
B7
Trichophyton rubrum
60D
clinical strain
B0-B7
184
clinical strain
B6-B7
235
clinical strain
B7
Trichophyton roseum
IHEM1535
BCCM/IHEM
B0-B7
7941
clinical strain
B6-B7
IHEM2478
BCCM/IHEM
B7
Trichophyton soudanense243
clinical strain
B0-B7
095
clinical strain
B6-B7
1100082clinical strainB7

BCCM/IHEM: Scientific Institute of Public Health, Mycology & Aerobiology Section, Brussels, Belgium; the characteristics of the mass spectra libraries B0 to B7 are described in Table 7.

Details of the 90 reference strains corresponding to 30 filamentous fungi species of medical interest included in the reference libraries BCCM/IHEM: Scientific Institute of Public Health, Mycology & Aerobiology Section, Brussels, Belgium; the characteristics of the mass spectra libraries B0 to B7 are described in Table 7.
Table 7

Architectural characteristics of the reference libraries

Library numberNumber of raw spectra per RMSNumber of RMS per strainNumber of strains per speciesLibrary characteristics
B0
4
1
1
1 RMS4 x 30 strains
B1
10
1
1
1 RMS10 x 30 strains
B2
10
2
1
2 RMS10 x 30 strains
B3
10
4
1
4 RMS10 x 30 strains
B4
20
2
1
2 RMS20 x 30 strains
B5
40
1
1
1 RMS40 x 30 strains
B6
10
4
2
4 RMS10 x 60 strains
B710434 RMS10 x 90 strains
Architectural characteristics of the reference libraries

Culture

Each reference strain was subcultured on four Sabouraud Gentamicin Chloramphenicol agar plates (AES, France) at 30°C. The strains used to construct the reference libraries and the isolates obtained from clinical samples were analyzed as soon as a fungal colony grew on the agar (usually after 48–72 hours). The clinical isolates were identified via morphological assessment, DNA sequencing, and MALDI-TOF MS as described below.

Clinical isolate identification

All 200 clinical isolates were identified in parallel by two trained mycologists following the identification keys of the Atlas of Clinical Fungi [24]. If the morphological identification was impossible or conflicted with the MALDI-TOF MS-based identification results, the isolate was further analyzed using DNA sequencing. DNA sequence-based identification was performed by analyzing the ITS 2 (primer ITS3: GCA TCG ATG AAG AAC GCA GC and primer ITS4c: TCC TCC GCT TAT TGA TAT GC) and D1-D2 (primer D1: AAC TTA AGC ATA TCA ATA AGC GGA GGA and primer D2: GGT CCG TGT TTC AAG ACG G) variable regions of the 28S unit of the rRNA gene as described by de Hoog et al. [24]. DNA extraction was performed using a QIAmp DNA kit (QIAGEN, Courtaboeuf, France). The reaction mixture was subjected to 35 cycles of 30 s denaturation at 94°C, 30 s primer annealing at 53°C, and 1 min primer extension at 72°C for the ITS 2 region and 40 cycles of 20 s denaturation at 94°C, 30 s primer annealing at 58°C, and 1 min primer extension at 72°C for the D1-D2 region. The sequencing reactions were performed using the same primers used for amplification. In both cases, the sequencing mixture was subjected to 25 cycles of 10 s denaturation at 96°C, 5 s primer annealing at 50°C, and 4 min primer extension at 60°C. Purification of the sequences was performed using BigDye® XTerminator™ (Applied Biosystems, Inc., Courtaboeuf, France), and the different reactions were processed using a 3130 Genetic Analyzer (Applied Biosystems, Inc., Courtaboeuf, France). The resulting sequences were then compared using the Medical Fungi pairwise sequence alignment tool (http://www.cbs.knaw.nl/Medical/BioloMICSSequences.aspx). Identification was validated when the sequence was at least 300 nucleotides long and the similarity percentage was over 98%.

Raw mass spectra acquisition

The colonies were gently scraped with sterile plastic pliers to obtain an aliquot (approximately 3–4 mm in diameter) of fungal spores and hyphae. This sample was first suspended in 75% ethanol HPLC. Next, the hydro-alcoholic solution was removed via 10 min centrifugation at 13,000 g, and the pellet was suspended in 10 μL of 70% formic acid (Sigma-Aldrich, France) by vigorously pipetting the sample up and down. After a 5-min incubation, 10 μL of acetonitrile HPLC (VWR International S.A.S., Fontenay-sous-Bois, France) was added, and the mixture was incubated at room temperature for 5 min. Finally, the sample was centrifuged for 2 min at 13,000 g. One microliter of the supernatant (consisting of a mixture of fungal proteins) was deposited for each reference strain subculture in 10 replicates on a polished steel target (MTP384, Bruker Daltonics GmbH, Bremen, Germany) and air-dried. Each deposit was then covered with 1 μL of a freshly prepared solution of α-cyano-4-hydroxycinnamic acid (HCCA) in 50% acetonitrile HPLC (VWR International S.A.S., Fontenay-sous-Bois, France) and 2.5% trifluoroacetic acid HPLC (TFA) matrix (Applied Biosystems®, Villebon sur yvette, France) [21]. The spectra were acquired after 650 shots in linear mode using an UltrafleXtreme™ instrument (Bruker Daltonics, Germany) in the ion-positive mode with a 337-nm nitrogen laser. The following adjustments were used: delay, 170 ns; ion source 1 voltage, 20 kV; ion source 2 voltage, 18.5 kV; mass range, 3–20 kDa; and measuring raster: spiral_small. An E. coli calibration was performed before every experiment using a Bruker Bacterial Test Standard (Bruker Daltonics GmbH, Bremen, Germany). The data were automatically acquired using the AutoXecute function of the FlexControl v2.4 software and then exported into MALDI Biotyper v2.1 (Bruker Daltonics) software. Only the peaks with a signal/noise ratio ≥10 were considered.

Constructing the reference mass spectra (RMS)

The RMS were established by combining i) 4 raw spectra obtained from one subculture (RMS4); ii) 10 raw spectra obtained from one subculture (RMS10); iii) 20 raw spectra, 10 from two subcultures each (RMS20); or iv) 40 raw spectra, 10 from four subcultures each (RMS40) of a given reference strain using the “MSP creation” function of the MALDI Biotyper v2.1 software (Table 7). The following settings were applied (Bruker’s default parameters): Max. Mass Error of each single spectrum: 2000; Desired Mass Error of the MSP: 200; Desired Peak Frequency Minimum: 25%; and Max. Desired Peak Number of the MSP: 70. The modulation of the number of peaks and desired peak frequency minimum of the MSP creation parameters has been tested regarding the B1 library, and the modified parameters were tested on the B7 database (Table 4).

Architecture of the eight mass spectral libraries

The same fungal species were included in the eight libraries that differed in number of raw spectra used to build the RMS (described above), RMS included for each reference strain, and strains included. The characteristics of the various libraries are detailed in Table 2.

MALDI-TOF MS–based identification of clinical isolates

Raw mass spectra were obtained from clinical isolates using the same procedure as for the reference strains with the exception that the supernatant were deposited in quadruplicate. The deposits, referred to as spots 1, 2, 3, and 4, correspond to the first, second, third, and fourth extraction supernatant deposit of each sample, respectively. The raw MS data for each spot was successively matched to the eight reference libraries, and the resulting “best match” LS values were calculated using MALDI Biotyper software. An alternate identification process was assessed by constructing an MSP with the four spots corresponding to each of the clinical isolates and comparing isolate MSP with each of the RMS in the libraries. The interpretation of the results was initially performed independently of the LS value. If the MS identification was identical to the microscopic identification or the sequencing analysis results, the identification was considered concordant, regardless of the LS value; otherwise, it was considered a non-concordant identification. Next, the LS value was considered to be applicable in comparing the performance of the various libraries. As approximately half of the clinical isolates corresponded to the Aspergillus fumigatus species, a comparison was also performed between the libraries when either considering or disregarding this dominant species. Library performance was also compared regarding the method by which the clinical quadruplicates were considered as follows: i) each spectrum was treated independently, ii) only the spectrum with the highest LS was taken into account, regardless of whether it was concordant, and iii) an MSP of the four spectra was constructed, and the clinical MSP was compared to each library.

Ambiguous MS identifications

Some of the species included in this study are known to be difficult to distinguish, even via ITS sequencing. Reference spectra were included in the libraries, but concordance could neither be confirmed nor contradicted. The species included were Penicillium aurantiogriseum and Penicillium chrysogenum. Both MS identifications were then considered concordant with the other identification methods.

Reference mass spectra library architecture assessment

Analyzing 200 clinical isolates, we tested the influence of the number of the following parameters on identification effectiveness: i) raw spectra used to build a reference MS, ii) reference MS included per strain, and iii) strains per species included in the library. The various reference spectrum architectures were compared with respect to the number of correct and false identifications as well as the mean LS values of both correct and false identifications.

Statistical analysis

The concordant and non-concordant identification results were compared two by two using the paired and non-parametric McNemar’s test. The results of the quantitative variable LS analysis were compared using the non-parametric rank sum test of the Kruskall-Wallis test. When the results of the Kruskall-Wallis test indicated a statistical difference between the LS values derived from the different mass spectral libraries, a post hoc statistical analysis was performed, which involved a pairwise comparison of the LS values obtained from each library using the Wilcoxon signed-rank test with Bonferroni adjustment. These analyses were performed using R software (http://www.r-project.org/) with the MASS and ROCR packages. To further examine the influence of library architecture on the probability of obtaining a correct identification, a multivariate analysis was conducted with the Genmod procedure of the SAS 9.2 (Cary, NC, USA) statistical software using the generalized estimating equations option to account for the non-independence of identification results obtained from the same isolate tested against distinct libraries. These analyses were performed to identify the optimal reference library architecture; therefore, the results obtained with isolates for which the species was not included in the library were excluded from this multivariate analysis. All statistical tests were two-sided with a p≤ 0.05 significance level.

Availability of supporting data

These data are included in Table 6 entitled “Details of the 90 reference strains included in the reference libraries”.

Abbreviations

MALDI-TOF: Matrix-assisted laser desorption/ionization time-of-flight; MS: Mass Spectrometry; RMS: Reference Meta Spectrum; MSP: Meta spectrum; LS: Log Score; PCR: Polymerase Chain Reaction; DNA: Deoxyribonucleic acid; rRNA: Ribosomal ribonucleic acid; s: Second; °C: Temperature in Celsius; min: Minute; μL: Microliter; nm: Nanometer; ns: Nanosecond; kV: Kilovolt; kDa: Kilodalton; MSL: Mass spectra library; Nb.: Number.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

ACN, CC, CL, PF, SR, and MH performed the experiments. ACN, CC, SR, and RP conceived the study, analyzed the data, and wrote the manuscript. CC and SR carried out the statistical analyses. ACN and CC prepared the figures and tables. All authors read and approved the final manuscript.
  21 in total

Review 1.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry.

Authors:  Laure F Marvin; Matthew A Roberts; Laurent B Fay
Journal:  Clin Chim Acta       Date:  2003-11       Impact factor: 3.786

Review 2.  Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology.

Authors:  Antony Croxatto; Guy Prod'hom; Gilbert Greub
Journal:  FEMS Microbiol Rev       Date:  2011-08-22       Impact factor: 16.408

3.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species.

Authors:  A Alanio; J-L Beretti; B Dauphin; E Mellado; G Quesne; C Lacroix; A Amara; P Berche; X Nassif; M-E Bougnoux
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

4.  Identification of dermatophyte species causing onychomycosis and tinea pedis by MALDI-TOF mass spectrometry.

Authors:  Marcel Erhard; Uta-Christina Hipler; Anke Burmester; Axel A Brakhage; Johannes Wöstemeyer
Journal:  Exp Dermatol       Date:  2007-11-02       Impact factor: 3.960

5.  Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  E De Carolis; B Posteraro; C Lass-Flörl; A Vella; A R Florio; R Torelli; C Girmenia; C Colozza; A M Tortorano; M Sanguinetti; G Fadda
Journal:  Clin Microbiol Infect       Date:  2011-08-29       Impact factor: 8.067

Review 6.  Diagnosis of fungal infection: new technologies for the mycology laboratory.

Authors:  B D Alexander
Journal:  Transpl Infect Dis       Date:  2002       Impact factor: 2.228

7.  A MALDI-TOF MS procedure for clinical dermatophyte species identification in the routine laboratory.

Authors:  Coralie L'Ollivier; Carole Cassagne; Anne-Cecile Normand; Jean-Philippe Bouchara; Nelly Contet-Audonneau; Marijke Hendrickx; Patrick Fourquet; Oumar Coulibaly; Renaud Piarroux; Stephane Ranque
Journal:  Med Mycol       Date:  2013-04-23       Impact factor: 4.076

8.  Detection of pathogenic Verticillium spp. using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Jie Tao; Guiming Zhang; Zide Jiang; Yinghui Cheng; Jianjun Feng; Zhinan Chen
Journal:  Rapid Commun Mass Spectrom       Date:  2009-12       Impact factor: 2.419

9.  Use of mass spectrometry to identify clinical Fusarium isolates.

Authors:  C Marinach-Patrice; A Lethuillier; A Marly; J-Y Brossas; J Gené; F Symoens; A Datry; J Guarro; D Mazier; C Hennequin
Journal:  Clin Microbiol Infect       Date:  2009-05-18       Impact factor: 8.067

10.  Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Carole Cassagne; Stéphane Ranque; Anne-Cécile Normand; Patrick Fourquet; Sandrine Thiebault; Chantal Planard; Marijke Hendrickx; Renaud Piarroux
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

View more
  29 in total

1.  Evaluation of the Bruker Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) System for the Identification of Clinically Important Dermatophyte Species.

Authors:  Nilgün Karabıçak; Onur Karatuna; Macit İlkit; Işın Akyar
Journal:  Mycopathologia       Date:  2015-05-14       Impact factor: 2.574

2.  Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus.

Authors:  David Triest; Dirk Stubbe; Koen De Cremer; Denis Piérard; Anne-Cécile Normand; Renaud Piarroux; Monique Detandt; Marijke Hendrickx
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

3.  Identification of fungal isolates by MALDI-TOF mass spectrometry in veterinary practice: validation of a web application.

Authors:  Pierre Becker; Anne-Cécile Normand; Gerty Vanantwerpen; Mia Vanrobaeys; Roel Haesendonck; Francis Vercammen; Dirk Stubbe; Renaud Piarroux; Marijke Hendrickx
Journal:  J Vet Diagn Invest       Date:  2019-04-04       Impact factor: 1.279

4.  Validation of a New Web Application for Identification of Fungi by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  A C Normand; P Becker; F Gabriel; C Cassagne; I Accoceberry; M Gari-Toussaint; L Hasseine; D De Geyter; D Pierard; I Surmont; F Djenad; J L Donnadieu; M Piarroux; S Ranque; M Hendrickx; R Piarroux
Journal:  J Clin Microbiol       Date:  2017-06-21       Impact factor: 5.948

5.  MALDI-TOF-Based Dermatophyte Identification.

Authors:  Coralie L'Ollivier; Stéphane Ranque
Journal:  Mycopathologia       Date:  2016-10-12       Impact factor: 2.574

6.  Fast and accurate identification of dermatophytes by matrix-assisted laser desorption ionization-time of flight mass spectrometry: validation in the clinical laboratory.

Authors:  A Packeu; A De Bel; C l'Ollivier; S Ranque; M Detandt; M Hendrickx
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 7.  MALDI-TOF mass spectrometry: any use for Aspergilli?

Authors:  Maurizio Sanguinetti; Brunella Posteraro
Journal:  Mycopathologia       Date:  2014-07-08       Impact factor: 2.574

8.  Use of the Bruker MALDI Biotyper for identification of molds in the clinical mycology laboratory.

Authors:  Bettina Schulthess; Raphael Ledermann; Forouhar Mouttet; Andrea Zbinden; Guido V Bloemberg; Erik C Böttger; Michael Hombach
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

9.  Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian Clinical Setting.

Authors:  Sue Sleiman; Catriona L Halliday; Belinda Chapman; Mitchell Brown; Joanne Nitschke; Anna F Lau; Sharon C-A Chen
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

10.  Identification of Leishmania by Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry Using a Free Web-Based Application and a Dedicated Mass-Spectral Library.

Authors:  Laurence Lachaud; Anna Fernández-Arévalo; Anne-Cécile Normand; Patrick Lami; Cécile Nabet; Jean Luc Donnadieu; Martine Piarroux; Farid Djenad; Carole Cassagne; Christophe Ravel; Silvia Tebar; Teresa Llovet; Denis Blanchet; Magalie Demar; Zoubir Harrat; Karim Aoun; Patrick Bastien; Carmen Muñoz; Montserrat Gállego; Renaud Piarroux
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.